| 000 | 01508 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516041825.0 | ||
| 264 | 0 | _c20110818 | |
| 008 | 201108s 0 0 eng d | ||
| 022 | _a1526-632X | ||
| 024 | 7 |
_a10.1212/WNL.0b013e31821e557a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSorarù, G | |
| 245 | 0 | 0 |
_aALS risk but not phenotype is affected by ataxin-2 intermediate length polyglutamine expansion. _h[electronic resource] |
| 260 |
_bNeurology _cJun 2011 |
||
| 300 |
_a2030-1 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAmyotrophic Lateral Sclerosis _xepidemiology |
| 650 | 0 | 4 | _aAtaxins |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDNA Repeat Expansion _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xchemistry |
| 650 | 0 | 4 |
_aPeptides _xgenetics |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aClementi, M | |
| 700 | 1 | _aForzan, M | |
| 700 | 1 | _aOrsetti, V | |
| 700 | 1 | _aD'Ascenzo, C | |
| 700 | 1 | _aQuerin, G | |
| 700 | 1 | _aPalmieri, A | |
| 700 | 1 | _aErmani, M | |
| 700 | 1 | _aAngelini, C | |
| 700 | 1 | _aPegoraro, E | |
| 773 | 0 |
_tNeurology _gvol. 76 _gno. 23 _gp. 2030-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/WNL.0b013e31821e557a _zAvailable from publisher's website |
| 999 |
_c20904813 _d20904813 |
||